Baltimore-based Patient Capital Management has reaffirmed its investment thesis for UnitedHealth Group in its Q1 2026 investor letter. The firm's Patient Opportunity Equity Strategy reported a quarterly loss of 5.96%, slightly underperforming the broader market.
- Q1 2026 net return of -5.96% for Patient Opportunity Equity Strategy
- S&P 500 benchmark return of -4.33% for the same period
- Reaffirmation of long-term value thesis for UNH
- Utilization of a three-factor performance attribution model
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.